PEDIATRIC MULTI SYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH COVID-19
Recently a possible link has been reported between COVID-19 and Pediatric Multi-System Inflammatory Syndrome (PMIS) temporally associated with COVID-19.
As of May 12th, 102 suspect cases of PMIS have been reported by hospitals in New York State and are under investigation by the New York State Department of Health.
An individual aged < 21 years with:
- A minimum one-day history of subjective OR objective fever (≥ 100.4° F/38° C); AND
Either one or more of the following:
- Hypotension or shock (cardiogenic or vasogenic)
- Features of severe cardiac illness including but not limited to myocarditis, pericarditis, or valvulitis, significantly elevated troponin/pro-BNP, or coronary artery abnormalities
- Other severe end-organ involvement including but not limited to neurological or renal disease (excluding severe respiratory disease alone)
Two or more of the following:
- Maculopapular rash
- Bilateral non-purulent conjunctivitis
- Mucocutaneous inflammatory signs (mouth, hands, or feet)
- Acute gastrointestinal symptoms (diarrhea, vomiting, or abdominal pain); AND
- The absence of a more likely diagnosis of the illness, e.g., bacterial sepsis or other viral infection.
One or more of the following exposures in the 6 weeks prior to the onset of symptoms:
- Close contact with an individual with laboratory-confirmed SARS-CoV-2 infection.1
- Close contact with an individual with illness clinically compatible with COVID-19 disease who had close
- contact with an individual with laboratory-confirmed SARS-CoV-2 infection.1
- Travel to or residence in an area with sustained, ongoing community transmission of SARS-CoV-2.